Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Long-Term Investments (2014 - 2016)

Updated

Analysis

Immucell (ICCC) Long-Term Investments (2014 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 387.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 63.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 268.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.45 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 487,000.00
Mar 31, 2016 487,000.00
Dec 31, 2015 489,648.00
Sep 30, 2015 487,000.00
Dec 31, 2014 496,000.00
Sep 30, 2014 496,000.00
Jun 30, 2014 496,000.00
Mar 31, 2014 496,000.00
API Access

Immucell Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ICCC&period=max&api_key=YOUR_API_KEY